Corporate and strategic advisory firm dedicated to assisting emerging, turn-around and biotechnology and med-tech companies looking for partnering and collaborations.

We were founded in 2018 to address the broad underlying issues behind the deadly opioid crisis in America. To address this epidemic, our initiatives focus on the following three areas. •Improves Education for addicts,chronic pain patients and their families•Better technology for clinicians dealing with addiction and pain•New pharmaceutical options for treating pain and addiction

Chairman of both the Audit and Compensation CommitteesAbeona Therapeutics is a clinical-stage biopharmaceutical company focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups.

PlasmaTech Biopharmaceuticals, Inc., formerly Access Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on developing a range of pharmaceutical products primarily based upon its nanopolymer chemistry technologies and other drug delivery technologies. The Company has one marketed product licensed in the United States, China and Korea. Its MuGard is its marketed product for the management of oral mucositis, a frequent side-effect of cancer therapy. The Company licensed MuGard to RHEI Pharmaceuticals (RHEI) for commercialization in China. Its ProctiGard is its product being developed for the management of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region. LexaGard, is its formulation of the generic pharmaceutical agent, amlexanox, a drug with known anti-inflammatory and anti-allergic properties that has been approved and used in the United States, Japan and other countries.

A medical and consumer products company with the objective of improving patient compliance and management of patient outcomes in the areas of Asthma and Cardiology.

Producing and Managing Commercial TheaterM2 Productions, produces and manages local productions on all scales with or without financial involvement. We assist a Production by helping to develop Investment Proposals; Creating Investor Information Memorandums, Budgets, Recoupment Forecasts and Contracts.Our approach also covers the creation and maintenance of programs and merchandising, including design, printing, manufacturing and sales.

Bradley Woods & Co. Ltd. was formed in 1970 as a boutique research firm offering distinctive, independent research focused on the impact of U.S. Federal Government actions on the capital markets. The firm’s founders, drawing on talent developed in the research department of Mitchell Hutchins (now UBS Securities) and at Oppenheimer & Co. (now CIBC World Markets), joined forces with Washington, D.C. insiders to create a unique political research product. Leveraging knowledge of the mechanics and dynamics of government, the firm’s goal has been and still is to digest the inner workings of the U.S. Federal Government’s activities and to interpret them in terms of their impact on equity and fixed income securities in the U.S.

Griffin Securities is a research-driven investment banking firm providing corporate finance, merger & acquisitions, brokerage, and investment opportunities for institutional, corporate, and private clients.

A highly successful value-oriented, long-biased life sciences group with 6-year healthcare value investing track record.

A specialized division of Ogilivy PR, focused exclusively on lifescience and healthcare communications, developing the services and strategies that best meet the specific needs of these sectors.

An investor relations, media relations and corporate communications agency to micro-, small- and mid-cap companies.

A leading investment bank and full-service investment firm that provides financial services and advice to high net worth investors, individuals, businesses and institutions.

Investment Bank and New York Stock Exchange Member Firm since 1879

Responsible for managing projects / activities from concept through completion to ensure timely execution and adherence to budget. Prepared written communications for faculty and clients related to specific projects. Identified, recruited and managed faculty as needed. Tracked association and journal deadlines for submission of applications and materials.

Before merging with Clifford Chance, the US arm of the firm was called Rogers & Wells. Rogers & Wells, a 128-year-old gentleman’s firm that included players like William Rogers, Richard Nixon’s first Secretary of State, and Anthony Essaye, executive director of the Clinton Legal Expense Trust.One of the worlds leading and largest law firms.